Tareq Affouri

Barrington Research initiated coverage on PharMerica Corporation (NYSE: PMC) Thursday with an Outperform rating and $30 price target. Analysts Michael Petusky and Tareq Affouri noted that the company is well positioned to benefit from several macro-related tailwinds "...including “...